Search

Search Constraints

You searched for: Author/Creator Rubinstein, Samuel M.

Search Results

2. BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy. (16th December 2017)

4. Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma. Issue 12 (15th October 2019)

5. Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social Vulnerability. Issue 2 (6th February 2023)

6. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. Issue 2 (March 2022)

9. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders. Issue 7 (September 2022)

10. Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents. (21st April 2020)